Ocular Therapeutix, Inc.
OCUL
$11.40
$0.151.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 344.77M | 391.13M | 349.68M | 392.10M | 427.22M |
| Total Receivables | 30.77M | 30.73M | 25.22M | 32.56M | 30.65M |
| Inventory | 3.49M | 3.04M | 3.27M | 3.04M | 2.41M |
| Prepaid Expenses | 7.95M | 8.47M | 9.52M | 13.28M | 12.74M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 386.98M | 433.38M | 387.69M | 440.99M | 473.01M |
|
|
|||||
| Total Current Assets | 386.98M | 433.38M | 387.69M | 440.99M | 473.01M |
| Net Property, Plant & Equipment | 22.29M | 16.34M | 16.61M | 15.33M | 15.74M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.61M | 1.61M | 1.61M | 1.61M | 1.61M |
| Total Assets | 410.88M | 451.33M | 405.92M | 457.94M | 490.37M |
|
|
|||||
| Total Accounts Payable | 6.26M | 5.89M | 4.63M | 4.18M | 4.00M |
| Total Accrued Expenses | 40.27M | 34.42M | 31.08M | 35.12M | 30.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.76M | 2.63M | 2.16M | 1.93M | 1.72M |
| Total Finance Division Other Current Liabilities | -- | -- | 64.00K | 128.00K | 190.00K |
| Total Other Current Liabilities | -- | -- | 64.00K | 128.00K | 190.00K |
| Total Current Liabilities | 49.29M | 42.93M | 37.93M | 41.35M | 36.36M |
|
|
|||||
| Total Current Liabilities | 49.29M | 42.93M | 37.93M | 41.35M | 36.36M |
| Long-Term Debt | 70.62M | 69.91M | 69.20M | 68.51M | 67.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.63M | 4.41M | 4.87M | 5.35M | 5.59M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 29.11M | 28.17M | 28.00M | 27.39M | 28.58M |
| Total Liabilities | 152.65M | 145.42M | 139.99M | 142.59M | 138.35M |
|
|
|||||
| Common Stock & APIC | 1.35B | 1.33B | 1.22B | 1.21B | 1.19B |
| Retained Earnings | -1.09B | -1.02B | -955.14M | -891.08M | -842.70M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 258.23M | 305.92M | 265.93M | 315.34M | 352.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 258.23M | 305.92M | 265.93M | 315.34M | 352.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 258.23M | 305.92M | 265.93M | 315.34M | 352.02M |
|
|
|||||